• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cardiovasc Diabetol . Epicardial adipose tissue and severe Coronavirus Disease 19

tetano

Editor, Senior Moderator
Cardiovasc Diabetol


. 2021 Jul 20;20(1):147.
doi: 10.1186/s12933-021-01329-z.
Epicardial adipose tissue and severe Coronavirus Disease 19


Hélène Bihan[SUP] 1 [/SUP], Richard Heidar[SUP] 2 [/SUP], Aude Beloeuvre[SUP] 3 [/SUP], Lucie Allard[SUP] 4 [/SUP], Elise Ouedraogo[SUP] 5 [/SUP], Sopio Tatulashvili[SUP] 4 [/SUP], Yacine Tandjaoui[SUP] 3 [/SUP], Stephane Gaudry[SUP] 3 [/SUP], Pierre-Yves Brillet[SUP] 2 [/SUP], Emmanuel Cosson[SUP] 4 6 [/SUP]



Affiliations

Abstract

Background: Both visceral adipose tissue and epicardial adipose tissue (EAT) have pro-inflammatory properties. The former is associated with Coronavirus Disease 19 (COVID-19) severity. We aimed to investigate whether an association also exists for EAT.
Material and methods: We retrospectively measured EAT volume using computed tomography (CT) scans (semi-automatic software) of inpatients with COVID-19 and analyzed the correlation between EAT volume and anthropometric characteristics and comorbidities. We then analyzed the clinicobiological and radiological parameters associated with severe COVID-19 (O2 [Formula: see text] 6 l/min), intensive care unit (ICU) admission or death, and 25% or more CT lung involvement, which are three key indicators of COVID-19 severity.
Results: We included 100 consecutive patients; 63% were men, mean age was 61.8 ± 16.2 years, 47% were obese, 54% had hypertension, 42% diabetes, and 17.2% a cardiovascular event history. Severe COVID-19 (n = 35, 35%) was associated with EAT volume (132 ± 62 vs 104 ± 40 cm[SUP]3[/SUP], p = 0.02), age, ferritinemia, and 25% or more CT lung involvement. ICU admission or death (n = 14, 14%) was associated with EAT volume (153 ± 67 vs 108 ± 45 cm[SUP]3[/SUP], p = 0.015), hypertension and 25% or more CT lung involvement. The association between EAT volume and severe COVID-19 remained after adjustment for sex, BMI, ferritinemia and lung involvement, but not after adjustment for age. Instead, the association between EAT volume and ICU admission or death remained after adjustment for all five of these parameters.
Conclusions: Our results suggest that measuring EAT volume on chest CT scans at hospital admission in patients diagnosed with COVID-19 might help to assess the risk of disease aggravation.

Keywords: COVID-19; Epicardial adipose tissue (EAT); Epicardial fat volume; Inflammation.
 
Back
Top Bottom